Scutellarin Alleviates Ovalbumin-Induced Airway Remodeling in Mice and TGF-β-Induced Pro-fibrotic Phenotype in Human Bronchial Epithelial Cells via MAPK and Smad2/3 Signaling Pathways
Inflammation - Trang 1-21 - 2024
Tóm tắt
Asthma is a chronic inflammatory disease characterized by airway hyperresponsiveness (AHR), inflammation, and remodeling. Epithelial-mesenchymal transition (EMT) is an essential player in these alterations. Scutellarin is isolated from Erigeron breviscapus. Its vascular relaxative, myocardial protective, and anti-inflammatory effects have been well established. This study was designed to detect the biological roles of scutellarin in asthma and its related mechanisms. The asthma-like conditions were induced by ovalbumin challenges. The airway resistance and dynamic compliance were recorded as the results of AHR. Bronchoalveolar lavage fluid (BALF) was collected and processed for differential cell counting. Hematoxylin and eosin staining, periodic acid-Schiff staining, and Masson staining were conducted to examine histopathological changes. The levels of asthma-related cytokines were measured by enzyme-linked immunosorbent assay. For in vitro analysis, the 16HBE cells were stimulated with 10 ng/mL transforming growth beta-1 (TGF-β1). Cell migration was estimated by Transwell assays and wound healing assays. E-cadherin, N-cadherin, and α-smooth muscle actin (α-SMA) were analyzed by western blotting, real-time quantitative polymerase chain reaction, immunofluorescence staining, and immunohistochemistry staining. The underlying mechanisms of the mitogen-activated protein kinase (MAPK) and Smad pathways were investigated by western blotting. In an ovalbumin-induced asthmatic mouse model, scutellarin suppressed inflammation and inflammatory cell infiltration into the lungs and attenuated AHR and airway remodeling. Additionally, scutellarin inhibited airway EMT (upregulated E-cadherin level and downregulated N-cadherin and α-SMA) in ovalbumin-challenged asthmatic mice. For in vitro analysis, scutellarin prevented the TGF-β1-induced migration and EMT in 16HBE cells. Mechanistically, scutellarin inhibits the phosphorylation of Smad2, Smad3, ERK, JNK, and p38 in vitro and in vivo. In conclusion, scutellarin can inactivate the Smad/MAPK pathways to suppress the TGF-β1-stimulated epithelial fibrosis and EMT and relieve airway inflammation and remodeling in asthma. This study provides a potential therapeutic strategy for asthma.
Tài liệu tham khảo
Wang, Z., Y. Li, Y. Gao, Y. Fu, J. Lin, X. Lei, et al. 2023. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respiratory Research 24 (1): 169.
Chen, Z.H., P.L. Wang, and H.H. Shen. 2013. Asthma research in China: a five-year review. Respirology 18 (Suppl 3): 10–19.
Wang, W.Y., J.T. Lin, N. Su, G.L. Liu, X.K. Feng, Q.Y. He, et al. 2013. Survey on the prevalence rate of bronchial asthma in Beijing area among the residents aged over 14 years from 2010 to 2011. Zhonghua Yi Xue Za Zhi 93 (18): 1383–1387.
Mims, J.W. 2015. Asthma: Definitions and pathophysiology. International Forum of Allergy & Rhinology 5 (Suppl 1): S2–S6.
Asher, I., and N. Pearce. 2014. Global burden of asthma among children. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease 18 (11): 1269–1278.
Nunes, C., A.M. Pereira, and M. Morais-Almeida. 2017. Asthma costs and social impact. Asthma Research and Practice 3: 1.
Heffler, E., L.N.G. Madeira, M. Ferrando, F. Puggioni, F. Racca, L. Malvezzi, et al. 2018. Inhaled corticosteroids safety and adverse effects in patients with asthma. The Journal of Allergy and Clinical Immunology in Practice 6 (3): 776–781.
Humbert, M., J. Bousquet, C. Bachert, O. Palomares, P. Pfister, I. Kottakis, et al. 2019. IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy. The Journal of Allergy and Clinical Immunology in Practice 7 (5): 1418–1429.
Lambrecht, B.N., and H. Hammad. 2015. The immunology of asthma. Nature Immunology 16 (1): 45–56.
Cho, J.Y. 2011. Recent advances in mechanisms and treatments of airway remodeling in asthma: A message from the bench side to the clinic. The Korean Journal of Internal Medicine 26 (4): 367–383.
Bartemes, K.R., and H. Kita. 2012. Dynamic role of epithelium-derived cytokines in asthma. Clinical Immunology 143 (3): 222–235.
Fahy, J.V. 2015. Type 2 inflammation in asthma–present in most, absent in many. Nature Reviews Immunology 15 (1): 57–65.
Hirota, N., and J.G. Martin. 2013. Mechanisms of airway remodeling. Chest 144 (3): 1026–1032.
Hackett, T.L. 2012. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Current Opinion in Allergy and Clinical Immunology 12 (1): 53–59.
Dou, D., M. Bi, X. Li, N. Zhang, M. Xu, A. Guo, et al. 2023. ADP ribosylation factor 6 relieves airway inflammation and remodeling by inhibiting ovalbumin induced-epithelial mesenchymal transition in experimental asthma, possibly by regulating of E2F transcription factor 8. Immunological Investigations 52: 717–734.
He, H., L. Cao, Z. Wang, Z. Wang, J. Miao, X.M. Li, et al. 2021. Sinomenine relieves airway remodeling by inhibiting epithelial-mesenchymal transition through downregulating TGF-β1 and Smad3 expression in vitro and in vivo. Frontiers in immunology 12: 736479.
Thevenot, P.T., J. Saravia, N. Jin, J.D. Giaimo, R.E. Chustz, S. Mahne, et al. 2013. Radical-containing ultrafine particulate matter initiates epithelial-to-mesenchymal transitions in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology 48 (2): 188–197.
Gong, J.H., I.H. Cho, D. Shin, S.Y. Han, S.H. Park, and Y.H. Kang. 2014. Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice. Laboratory Investigation: A Journal of Technical Methods and Pathology 94 (3): 297–308.
Wang, L., and Q. Ma. 2018. Clinical benefits and pharmacology of scutellarin: a comprehensive review. Pharmacology & Therapeutics 190: 105–127.
Liu, Y., Y.Y. Jing, C.Y. Zeng, C.G. Li, L.H. Xu, L. Yan, et al. 2017. Scutellarin suppresses NLRP3 inflammasome activation in macrophages and protects mice against bacterial sepsis. Frontiers in Pharmacology 8: 975.
Zhu, J., L. Chen, Y. Qi, J. Feng, L. Zhu, Y. Bai, et al. 2018. Protective effects of Erigeron breviscapus Hand.- Mazz. (EBHM) extract in retinal neurodegeneration models. Molecular Vision 24: 315–325.
Fan, D., D. Wang, and L. Zhu. 2022. Protective role of scutellarin on LPS induced - acute lung injury and regulation of apoptosis, oxidative stress and reduction of mitochondrial dysfunction. Saudi Journal of Biological Sciences 29 (1): 371–378.
Ibrahim, M.A.A., W.M. Elwan, and H.A. Elgendy. 2019. Role of scutellarin in ameliorating lung injury in a rat model of bilateral hind limb ischemia-reperfusion. Anatomical Record 302 (11): 2070–2081.
Jiang, D.P., J.M. Perelman, V.P. Kolosov, and X.D. Zhou. 2011. Effects of scutellarin on MUC5AC mucin production induced by human neutrophil elastase or interleukin 13 on airway epithelial cells. Journal of Korean Medical Science 26 (6): 778–784.
Peng, L., L. Wen, Q.F. Shi, F. Gao, B. Huang, J. Meng, et al. 2020. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death & Disease 11 (11): 978.
Zhou, H., X. Chen, L. Chen, X. Zhou, G. Zheng, H. Zhang, et al. 2014. Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats. Molecules 19 (10): 15611–15623.
Mantel, P.Y., and C.B. Schmidt-Weber. 2011. Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods in Molecular Biology 677: 303–338.
Al-Alawi, M., T. Hassan, and S.H. Chotirmall. 2014. Transforming growth factor β and severe asthma: a perfect storm. Respiratory Medicine 108 (10): 1409–1423.
Desai, P., J. Yang, B. Tian, H. Sun, M. Kalita, H. Ju, et al. 2015. Mixed-effects model of epithelial-mesenchymal transition reveals rewiring of signaling networks. Cellular Signalling 27 (7): 1413–1425.
You, J., J. Wang, L. Xie, C. Zhu, and J. Xiong. 2016. D-4F, an apolipoprotein A-I mimetic, inhibits TGF-β1 induced epithelial-mesenchymal transition in human alveolar epithelial cell. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft fur Toxikologische Pathologie 68 (9): 533–541.
Fan, Q., and Y. Jian. 2020. MiR-203a-3p regulates TGF-β1-induced epithelial-mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1. Bioscience Reports 40 (2): BSR20192645.
Li, Y., Y. Shen, M. Li, D. Su, W. Xu, X. Liang, et al. 2015. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes. Molecular and Cellular Biochemistry 405 (1–2): 233–241.
Hung, T.W., J.P. Tsai, S.H. Lin, C.H. Lee, Y.H. Hsieh, and H.R. Chang. 2016. Pentraxin 3 activates JNK signaling and regulates the epithelial-to-mesenchymal transition in renal fibrosis. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 40 (5): 1029–1038.
Li, Z., X. Liu, B. Wang, Y. Nie, J. Wen, Q. Wang, et al. 2017. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Nephrology 22 (8): 589–597.
Pan, Z., W. Zhao, X. Zhang, B. Wang, J. Wang, X. Sun, et al. 2011. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2. British Journal of Pharmacology 162 (3): 688–700.
Wang, W., Z. Yang, M. Li, Z. Wang, Y. Shan, and Z. Qu. 2021. Six1 promotes epithelial-mesenchymal transition in bronchial epithelial cells via the TGFβ1/Smad signalling pathway. International Archives of Allergy and Immunology 182 (6): 479–488.
Yang, Z.C., Z.H. Qu, M.J. Yi, Y.C. Shan, N. Ran, L. Xu, et al. 2019. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma. Journal of Cellular Physiology 234 (6): 8804–8814.
Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (4): 402–408.
Xiong, Y.Y., J.S. Wang, F.H. Wu, J. Li, and L.Y. Kong. 2012. The effects of (±)-Praeruptorin A on airway inflammation, remodeling and transforming growth factor-β1/Smad signaling pathway in a murine model of allergic asthma. International Immunopharmacology 14 (4): 392–400.
Liang, S., Y. Zhao, G. Chen, and C. Wang. 2022. Isoorientin ameliorates OVA-induced asthma in a murine model of asthma. Experimental Biology and Medicine 247 (16): 1479–1488.
Liu, Y. 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology 21 (2): 212–222.
Kim, D.I., M.K. Song, and K. Lee. 2019. Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes. BMC Pulmonary Medicine 19 (1): 241.
Ye, J., B. Zeng, M. Zhong, H. Li, L. Xu, J. Shu, et al. 2021. Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling. Acta Pharmaceutica Sinica B 11 (1): 112–126.
Xi, J., Y. Rong, Z. Zhao, Y. Huang, P. Wang, H. Luan, et al. 2021. Scutellarin ameliorates high glucose-induced vascular endothelial cells injury by activating PINK1/Parkin-mediated mitophagy. Journal of Ethnopharmacology 271: 113855.
Wang, Z., J. Yu, J. Wu, F. Qi, H. Wang, Z. Wang, et al. 2016. Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Life Sciences 157: 200–207.
Bullone, M., and J.P. Lavoie. 2020. The equine asthma model of airway remodeling: from a veterinary to a human perspective. Cell and Tissue Research 380 (2): 223–236.
Banno, A., A.T. Reddy, S.P. Lakshmi, and R.C. Reddy. 2020. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Clinical Science 134 (9): 1063–1079.
Boulet, L.P. 2018. Airway remodeling in asthma: Update on mechanisms and therapeutic approaches. Current Opinion in Pulmonary Medicine 24 (1): 56–62.
Turner, J., and C.E. Jones. 2009. Regulation of mucin expression in respiratory diseases. Biochemical Society Transactions 37 (Pt 4): 877–881.
Jiang, D.P., Q. Li, J. Yang, J.M. Perelman, V.P. Kolosov, and X.D. Zhou. 2011. Scutellarin attenuates human-neutrophil-elastase-induced mucus production by inhibiting the PKC-ERK signaling pathway in vitro and in vivo. The American Journal of Chinese Medicine 39 (6): 1193–1206.
Hamid, Q., and M. Tulic. 2009. Immunobiology of asthma. Annual Review of Physiology 71: 489–507.
Adcock, I.M., G. Caramori, and K.F. Chung. 2008. New targets for drug development in asthma. Lancet 372 (9643): 1073–1087.
Holgate, S.T., and R. Polosa. 2008. Treatment strategies for allergy and asthma. Nature Reviews Immunology 8 (3): 218–230.
Afshar, R., B.D. Medoff, and A.D. Luster. 2008. Allergic asthma: A tale of many T cells. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 38 (12): 1847–1857.
Kay, A.B., S. Phipps, and D.S. Robinson. 2004. A role for eosinophils in airway remodelling in asthma. Trends in Immunology 25 (9): 477–482.
Januskevicius, A., S. Vaitkiene, R. Gosens, I. Janulaityte, D. Hoppenot, R. Sakalauskas, et al. 2016. Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma. BMC Pulmonary Medicine 16 (1): 94.
Pease, J.E., and T.J. Williams. 2001. Eotaxin and asthma. Current Opinion in Pharmacology 1 (3): 248–253.
Luo, Z., Z. Hu, Y. Bian, W. Su, X. Li, S. Li, et al. 2020. Scutellarin attenuates the IL-1β-induced inflammation in mouse chondrocytes and prevents osteoarthritic progression. Frontiers in Pharmacology 11: 107.
Zhang, L., S. Sun, W. Li, W. Zhang, X. Wang, and S.Y. Yang. 2017. Effect of scutellarin inhibits collagen-induced arthritis through TLR4/NF-κB-mediated inflammation. Molecular Medicine Reports 16 (4): 5555–5560.
Sun, C.Y., J. Nie, Z.L. Zheng, J. Zhao, L.M. Wu, Y. Zhu, et al. 2019. Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: Impact on inflammation, apoptosis, and autophagy. Biomedicine & Pharmacotherapy 112: 108647.
Pastushenko, I., and C. Blanpain. 2019. EMT transition states during tumor progression and metastasis. Trends in Cell Biology 29 (3): 212–226.
Stone, R.C., I. Pastar, N. Ojeh, V. Chen, S. Liu, K.I. Garzon, et al. 2016. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell and Tissue Research 365 (3): 495–506.
Derynck, R., and R.A. Weinberg. 2019. EMT and cancer: more than meets the eye. Developmental Cell 49 (3): 313–316.
Jendzjowsky, N.G., and M.M. Kelly. 2019. The role of airway myofibroblasts in asthma. Chest 156 (6): 1254–1267.
Michalik, M., K. Wójcik-Pszczoła, M. Paw, D. Wnuk, P. Koczurkiewicz, M. Sanak, et al. 2018. Fibroblast-to-myofibroblast transition in bronchial asthma. Cellular and Molecular Life Sciences 75 (21): 3943–3961.
Itoigawa, Y., N. Harada, S. Harada, Y. Katsura, F. Makino, J. Ito, et al. 2015. TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells. Respiratory Research 16 (1): 48.
Song, L., S. Sen, Y. Sun, J. Zhou, L. Mo, and Y. He. 2016. Ketamine inhalation ameliorates ovalbumin-induced murine asthma by suppressing the epithelial-mesenchymal transition. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22: 2471–2483.
Park, J.A., L. Atia, J.A. Mitchel, J.J. Fredberg, and J.P. Butler. 2016. Collective migration and cell jamming in asthma, cancer and development. Journal of Cell Science 129 (18): 3375–3383.
Li, F., S. Wang, and M. Niu. 2021. Scutellarin inhibits the growth and EMT of gastric cancer cells through regulating PTEN/PI3K pathway. Biological & Pharmaceutical Bulletin 44 (6): 780–788.
Lv, W.L., Q. Liu, J.H. An, and X.Y. Song. 2019. Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells. Journal of Cellular Physiology 234 (12): 23169–23175.
Li, C.Y., Q. Wang, X. Wang, G. Li, S. Shen, and X. Wei. 2019. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway. European Journal of Pharmacology 858: 172463.
Sun, X., L. Zhou, Y. Han, Q. Yang, X. Li, B. Xin, et al. 2023. Scutellarin attenuates doxorubicin-induced cardiotoxicity by inhibiting myocardial fibrosis, apoptosis and autophagy in rats. Chemistry & Biodiversity 20 (1): e202200450.
Huo, Y., A. Mijiti, R. Cai, Z. Gao, M. Aini, A. Mijiti, et al. 2021. Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice. Human & Experimental Toxicology 40 (12_suppl): S460–S474.
Xu, L., R. Chen, X. Zhang, Y. Zhu, X. Ma, G. Sun, et al. 2021. Scutellarin protects against diabetic cardiomyopathy via inhibiting oxidative stress and inflammatory response in mice. Annals of Palliative Medicine 10 (3): 2481–2493.
Pu, Y., Y.Q. Liu, Y. Zhou, Y.F. Qi, S.P. Liao, S.K. Miao, et al. 2020. Dual role of RACK1 in airway epithelial mesenchymal transition and apoptosis. Journal of Cellular and Molecular Medicine 24 (6): 3656–3668.
Geng, X.Q., A. Ma, J.Z. He, L. Wang, Y.L. Jia, G.Y. Shao, et al. 2020. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways. Acta Pharmacologica Sinica 41 (5): 670–677.
Lee, J.H., and J. Massagué. 2022. TGF-β in developmental and fibrogenic EMTs. Seminars in Cancer Biology 86 (Pt 2): 136–145.
Guo, H., Z. Jian, H. Liu, H. Cui, H. Deng, J. Fang, et al. 2021. TGF-β1-induced EMT activation via both Smad-dependent and MAPK signaling pathways in Cu-induced pulmonary fibrosis. Toxicology and Applied Pharmacology 418: 115500.
Lan, H.Y. 2011. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. International Journal of Biological Sciences 7 (7): 1056–1067.
Ji, Y., Y.N. Dou, Q.W. Zhao, J.Z. Zhang, Y. Yang, T. Wang, et al. 2016. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Acta Pharmacologica Sinica 37 (6): 794–804.
Yang, H., Z. Wang, L. Wang, Y. Li, J. Guo, X. Yang, et al. 2022. Scutellarin ameliorates osteoarthritis by protecting chondrocytes and subchondral bone microstructure by inactivating NF-κB/MAPK signal transduction. Biomedicine & Pharmacotherapy 155: 113781.
Liu, F., L. Li, W. Lu, Z. Ding, W. Huang, Y.T. Li, et al. 2020. Scutellarin ameliorates cartilage degeneration in osteoarthritis by inhibiting the Wnt/β-catenin and MAPK signaling pathways. International Immunopharmacology 78: 105954.
Zhang, Y., Z. Zhang, J. Wang, X. Zhang, J. Zhao, N. Bai, et al. 2022. Scutellarin alleviates cerebral ischemia/reperfusion by suppressing oxidative stress and inflammatory responses via MAPK/NF-κB pathways in rats. Environmental Toxicology 37 (12): 2889–2896.
Chen, H.L., W.J. Jia, H.E. Li, H. Han, F. Li, X.L. Zhang, et al. 2020. Scutellarin exerts anti-inflammatory effects in activated microglia/brain macrophage in cerebral ischemia and in activated BV-2 microglia through regulation of MAPKs signaling pathway. Neuromolecular Medicine 22 (2): 264–277.
Wang, S., T. Wuniqiemu, W. Tang, F. Teng, Q. Bian, L. Yi, et al. 2021. Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex. International Immunopharmacology 94: 107460.
Zou, W., F. Ding, C. Niu, Z. Fu, and S. Liu. 2018. Brg1 aggravates airway inflammation in asthma via inhibition of the PI3K/Akt/mTOR pathway. Biochemical and Biophysical Research Communications 503 (4): 3212–3218.
Gong, R., X. Liu, and J. Zhao. 2023. Electroacupuncture-induced activation of GABAergic system alleviates airway inflammation in asthma model by suppressing TLR4/MyD88/NF-κB signaling pathway. Chinese Medical Journal 136 (4): 451–460.
Shang, L., L. Wang, X. Shi, N. Wang, L. Zhao, J. Wang, et al. 2020. HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-κB signal pathway in asthma. Life Sciences 241: 117120.
Shan, L., S. Liu, Q. Zhang, Q. Zhou, and Y. Shang. 2022. Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis. Cell Cycle 21 (4): 352–367.
Yang, X., J.N. Lv, H. Li, B. Jiao, Q.H. Zhang, Y. Zhang, et al. 2017. Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma. The Journal of Asthma: Official Journal of the Association for the Care of Asthma 54 (4): 335–340.